D. Harry

686 total citations
14 papers, 550 citations indexed

About

D. Harry is a scholar working on Surgery, Molecular Biology and Nephrology. According to data from OpenAlex, D. Harry has authored 14 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Nephrology. Recurrent topics in D. Harry's work include Liver Disease Diagnosis and Treatment (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). D. Harry is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). D. Harry collaborates with scholars based in United Kingdom, United States and Sweden. D. Harry's co-authors include Karima Zitouni, Kenneth Earle, Lucyna Bassan, L Kreel, Ala Sungoor, R.S.H. Istepanian, W F Pralong, Jozsef Z. Kiss, D. Baetens and Jochen Lang and has published in prestigious journals such as The EMBO Journal, Gastroenterology and Diabetes Care.

In The Last Decade

D. Harry

13 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Harry United Kingdom 9 151 115 110 87 77 14 550
Kazunori Otsui Japan 13 82 0.5× 16 0.1× 60 0.5× 75 0.9× 7 0.1× 34 708
Yilin Chen China 14 125 0.8× 11 0.1× 22 0.2× 44 0.5× 29 0.4× 54 684
Shirley St. George United Kingdom 13 47 0.3× 14 0.1× 79 0.7× 29 0.3× 8 0.1× 32 705
Shinuk Kim South Korea 10 66 0.4× 17 0.1× 30 0.3× 15 0.2× 17 0.2× 32 449
Patrick Kearns United States 6 36 0.2× 19 0.2× 47 0.4× 35 0.4× 12 0.2× 12 646
Hao Qian China 15 166 1.1× 6 0.1× 62 0.6× 35 0.4× 22 0.3× 33 675
Marta Skowrońska Poland 12 154 1.0× 8 0.1× 10 0.1× 57 0.7× 89 1.2× 34 551
Shunji Yamazaki Japan 12 109 0.7× 7 0.1× 88 0.8× 131 1.5× 12 0.2× 20 681

Countries citing papers authored by D. Harry

Since Specialization
Citations

This map shows the geographic impact of D. Harry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Harry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Harry more than expected).

Fields of papers citing papers by D. Harry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Harry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Harry. The network helps show where D. Harry may publish in the future.

Co-authorship network of co-authors of D. Harry

This figure shows the co-authorship network connecting the top 25 collaborators of D. Harry. A scholar is included among the top collaborators of D. Harry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Harry. D. Harry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Harry, D., et al.. (2015). Bladder squamous cell carcinoma in pregnancy. Journal of Obstetrics and Gynaecology. 36(3). 388–389. 3 indexed citations
2.
Istepanian, R.S.H., et al.. (2009). Evaluation of a mobile phone telemonitoring system for glycaemic control in patients with diabetes. Journal of Telemedicine and Telecare. 15(3). 125–128. 138 indexed citations
4.
Earle, Kenneth, D. Harry, & Karima Zitouni. (2007). Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 79(1). 68–73. 9 indexed citations
5.
Zitouni, Karima, D. Harry, Jaffar Nourooz‐Zadeh, D. J. Betteridge, & Kenneth Earle. (2005). Circulating vitamin E, transforming growth factor β1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes. Kidney International. 67(5). 1993–1998. 9 indexed citations
6.
Zitouni, Karima, Jaffar Nourooz‐Zadeh, D. Harry, et al.. (2005). Race-Specific Differences in Antioxidant Enzyme Activity in Patients With Type 2 Diabetes. Diabetes Care. 28(7). 1698–1703. 26 indexed citations
7.
Bergman, Antonina, Å. Magnusson, Anders Sundin, et al.. (1998). The efficacy of fp 736-04 in experimental liver cirrhosis. Acta Radiologica. 39(5). 568–571.
8.
Marley, Richard, et al.. (1997). 8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats. Gastroenterology. 112(1). 208–213. 37 indexed citations
9.
Loehrer, Patrick J., et al.. (1994). 5-Fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma. Investigational New Drugs. 12(1). 57–63. 22 indexed citations
10.
Kiss, Jozsef Z., Geneviève Rougon, Jochen Lang, et al.. (1994). Activity-dependent mobilization of the adhesion molecule polysialic NCAM to the cell surface of neurons and endocrine cells.. The EMBO Journal. 13(22). 5284–5292. 134 indexed citations
11.
Bydder, Graeme M., Roger W. Chapman, D. Harry, et al.. (1981). Computed tomography attenuation values in fatty liver. Journal of Computed Tomography. 5(1). 33–35. 87 indexed citations
12.
Bydder, G. M., L Kreel, Richard W. Chapman, et al.. (1980). Accuracy of computed tomography in diagnosis of fatty liver.. BMJ. 281(6247). 1042–1042. 77 indexed citations
13.
Day, R. C., D. Harry, James S. Owen, & Neil McIntyre. (1978). Plasma Lecithin—Cholesterol Acyl Transferase Activity and the Lipoprotein Abnormalities of Parenchymal Liver Disease. Clinical Science. 54(2). 36P–36P. 3 indexed citations
14.
Khan, Obaidullah, et al.. (1977). Studies in Lipogenesis in the Nephrotic Syndrome Produced in Rats with the Aminonucleoside of Puromycin. Clinical Science. 53(3). 4P–5P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026